Baraclude (entecavir), a new oral antiviral for chronic hepatitis B

May 2005

Some patients will get Baraclude (entecavir), a new oral antiviral for chronic hepatitis B.

It will be used as an alternative to Intron A (interferon alfa-2b)...Epivir-HBV (lamivudine)...or Hepsera (adefovir).

Intron A is effective for suppressing the hepatitis B virus and has a shorter treatment duration than the oral antivirals.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

the legality of writing multiple C-II Rxs on the same day, for the same patient, for the same drug
Antithrombotics high-dose aspirin to prevent recurrent stroke from INTRACRANIAL arterial stenosis
Antithrombotics patients are caught by surprise when fad diets or special foods interfere with their warfarin therapy
Neurology Pain New FDA warnings on NSAIDs and COX-2s are causing a return to basics for pain management
Neurology Pain certain generic versions of Duragesic don't seem to work as well
Bisphosphonates Boniva (ibandronate), the new once-MONTHLY bisphosphonate for osteoporosis
Bisphosphonates new warnings that bisphosphonates may cause jaw osteonecrosis
Infectious Diseases Baraclude (entecavir), a new oral antiviral for chronic hepatitis B
Infectious Diseases new IV antifungal, Mycamine (micafungin)
Thyroid Disorders Should patients with hypothyroidism be treated with both levothyroxine (Synthroid, etc) AND liothyronine (Cytomel)
Alzheimer s Disease Reminyl will be renamed Razadyne
Women s Health new form of Depo-Provera called Depo-subQ Provera 104
Women s Health New rumors suggest that Plan B is going OTC
Limbrel (flavocoxid) for osteoarthritis